Judge Blocks Cuts to $11 Billion in Public Health Funding
By I. Edwards HealthDay Reporter
FRIDAY, April 4, 2025 -- A federal judge has stopped the Trump administration from cutting $11 billion in public health funding -- at least for now.
U.S. District Judge Mary McElroy, who was appointed by President Donald Trump in 2019, said Thursday that she would grant a temporary restraining order. The request came from 23 states and the District of Columbia, who argued the cuts would hurt their ability to provide adequate medical care.
“They make a case, a strong case, for the fact that they will succeed on the merits, so I’m going to grant the temporary restraining order,” McElroy said, as reported by The Associated Press.
A written ruling will follow.
New York Attorney General Letitia James tweeted about the decision on X.
“We’re going to continue our lawsuit and fight to ensure states can provide the medical services Americans need,” James said.
The funding, approved by Congress during the pandemic, supports a wide range of programs, including COVID response and mental health care.
The states, who filed the lawsuit earlier this week, said loss of the funds would damage the U.S. public health system, cut off important services and make the country less prepared for future health emergencies.
Some states are already feeling the impact. Minnesota’s health department has laid off nearly 200 workers.
North Carolina says it could lose $230 million, while California expects to lose $1 billion, The Associated Press said.
Pennsylvania Governor Josh Shapiro said his state was at risk of losing a half-billion dollars. That money supports long-term care for older adults and vaccines for children.
“As a result of taking the Administration to court, these dollars will now start flowing again,” he wrote on X.
Assistant U.S. Attorney Leslie Kane objected to the judge’s decision in court but said her office didn’t have enough time to review the thousands of documents involved.
This ruling is one of many legal challenges to Trump’s policies. The administration is facing more than 150 lawsuits covering topics like immigration, cuts to federal programs and transgender rights.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-04-05 06:00
Read more

- AAOS: Header Ban Linked to Decrease in Soccer-Linked Concussions in Children
- Q32 Bio Presents Results from SIGNAL-AA Part A Clinical Trial Evaluating Bempikibart in Patients with Alopecia Areata
- AAD: Ivarmacitinib 4 mg, 8 mg Efficacious for Adults With Severe Alopecia Areata
- Omeros Corporation Provides Update of Ongoing Zaltenibart Phase 3 PNH Clinical Trial Program
- Amgen and Kyowa Kirin Provide Top-Line Results from Rocatinlimab Phase 3 Ignite Study in Adults with Moderate to Severe Atopic Dermatitis
- New Bill Targets Harmful Ingredients in California School Food
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions